Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
5 "Qi Li"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Sarcoma
Integrated Transcriptomic Landscape and Deep Learning Based Survival Prediction in Uterine Sarcomas
Yaolin Song, Guangqi Li, Zhenqi Zhang, Yinbo Liu, Huiqing Jia, Chao Zhang, Jigang Wang, Yanjiao Hu, Fengyun Hao, Xianglan Liu, Yunxia Xie, Ding Ma, Ganghua Li, Zaixian Tai, Xiaoming Xing
Cancer Res Treat. 2025;57(1):250-266.   Published online July 10, 2024
DOI: https://doi.org/10.4143/crt.2024.343
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The genomic characteristics of uterine sarcomas have not been fully elucidated. This study aimed to explore the genomic landscape of the uterine sarcomas (USs).
Materials and Methods
Comprehensive genomic analysis through RNA-sequencing was conducted. Gene fusion, differentially expressed genes (DEGs), signaling pathway enrichment, immune cell infiltration, and prognosis were analyzed. A deep learning model was constructed to predict the survival of US patients.
Results
A total of 71 US samples were examined, including 47 endometrial stromal sarcomas (ESS), 18 uterine leiomyosarcomas (uLMS), three adenosarcomas, two carcinosarcomas, and one uterine tumor resembling an ovarian sex-cord tumor. ESS (including high-grade ESS [HGESS] and low-grade ESS [LGESS]) and uLMS showed distinct gene fusion signatures; a novel gene fusion site, MRPS18A–PDC-AS1 could be a potential diagnostic marker for the pathology differential diagnosis of uLMS and ESS; 797 and 477 uterine sarcoma DEGs (uDEGs) were identified in the ESS vs. uLMS and HGESS vs. LGESS groups, respectively. The uDEGs were enriched in multiple pathways. Fifteen genes including LAMB4 were confirmed with prognostic value in USs; immune infiltration analysis revealed the prognositic value of myeloid dendritic cells, plasmacytoid dendritic cells, natural killer cells, macrophage M1, monocytes and hematopoietic stem cells in USs; the deep learning model named Max-Mean Non-Local multi-instance learning (MMN-MIL) showed satisfactory performance in predicting the survival of US patients, with the area under the receiver operating curve curve reached 0.909 and accuracy achieved 0.804.
Conclusion
USs harbored distinct gene fusion characteristics and gene expression features between HGESS, LGESS, and uLMS. The MMN-MIL model could effectively predict the survival of US patients.

Citations

Citations to this article as recorded by  
  • An interpretable model based on weakly supervised learning for uterine smooth muscle tumor diagnosis: A multi-center study
    Xiaoxi Wang, Xiaochen Shen, Moxuan Yang, Ling Yang, Ying He, Yanni Ren, Shuhao Wang, Dayi Wu, Yuanyuan Guo, Yiru Niu, Kaiyue Peng, Zhihui Wang, Jingpeng Wu, Jiacheng Li, Wei Wang, Feng Wang, Lijuan Cui, Wei Wang, Congrong Liu, Dingrong Zhong
    Pathology - Research and Practice.2026; 278: 156337.     CrossRef
  • Integrated mutational landscape analysis of endometrial stromal sarcoma
    Tobias M. P. Hartwich, Seungji Choi, Ayoung Hwang, Stefania Bellone, Luca Palmieri, Hae Seo, Taekeun Kim, Juhyeon Hong, Camilla Krakstad, Jone Trovik, Ingunn M. Stefansson, Hans Kristian Haugland, Michelle Greenman, Victoria Ettorre, Sarah Ottum, Cem Demi
    Proceedings of the National Academy of Sciences.2026;[Epub]     CrossRef
  • Mitochondrial Ribosomal Proteins and Cancer
    Huiyi Wu, Xiaowei Zhu, Huilin Zhou, Min Sha, Jun Ye, Hong Yu
    Medicina.2025; 61(1): 96.     CrossRef
  • Molecular Insights in Endometrial Stromal Sarcomas: Exploring New Targets for Novel Therapeutic Approaches
    Alice Costa, Annalisa Astolfi, Livia Gozzellino, Margherita Nannini, Gianandrea Pasquinelli, Maria Abbondanza Pantaleo
    Biomolecules.2025; 15(2): 265.     CrossRef
  • Uncertainty-driven hybrid-view adaptive learning for fully automated uterine leiomyosarcoma diagnosis
    Qi Li, Jingxian Wu, Xiyu Liu, Dengwang Li, Jie Xue
    Medical Image Analysis.2025; 105: 103692.     CrossRef
  • 2.5D deep learning radiomics and clinical data for predicting occult lymph node metastasis in lung adenocarcinoma
    Xiaoxin Huang, Xiaoxiao Huang, Kui Wang, Haosheng Bai, Xiuxian Lu, Guanqiao Jin
    BMC Medical Imaging.2025;[Epub]     CrossRef
  • A four-gene signature identified by integrated transcriptomic analysis for differential diagnosis and prognosis of uterine smooth muscle tumors
    Huiyi Hu, Yuanqun Chen, Bo Hong, Jia Liu, Yuchen Jiang, Zhiying Yu, Zhi-Jie Xiao, Jing Li
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • 4,555 View
  • 158 Download
  • 5 Web of Science
  • 7 Crossref
Close layer
Erratum
ERRATUM: Comparison between Craniospinal Irradiation and Limited-Field Radiation in Patients with Non-metastatic Bifocal Germinoma
Bo Li, Wenyi Lv, Chunde Li, Jiongxian Yang, Jiajia Chen, Jin Feng, Li Chen, Zhenyu Ma, Youqi Li, Jiayi Wang, Yanwei Liu, Yanong Li, Shuai Liu, Shiqi Luo, Xiaoguang Qiu
Cancer Res Treat. 2021;53(2):607.   Published online March 9, 2021
DOI: https://doi.org/10.4143/crt.2020.437.E
Corrects: Cancer Res Treat 2020;52(4):1050
PDFPubReaderePub
  • 4,338 View
  • 67 Download
Close layer
Original Article
Gastrointestinal cancer
Hepatitis B Virus Core Protein Mediates the Upregulation of C5α Receptor 1 via NF-κB Pathway to Facilitate the Growth and Migration of Hepatoma Cells
Fanyun Kong, Yukai Tao, Dongchen Yuan, Ning Zhang, Qi Li, Tong Yu, Xiaoying Yang, Delong Kong, Xiaohui Ding, Xiangye Liu, Hongjuan You, Kuiyang Zheng, Renxian Tang
Cancer Res Treat. 2021;53(2):506-527.   Published online November 16, 2020
DOI: https://doi.org/10.4143/crt.2020.397
AbstractAbstract PDFPubReaderePub
Purpose
C5α receptor 1 (C5ΑR1) is associated with the development of various human cancers. However, whether it is involved in the development of hepatitis B virus (HBV)–related hepatocellular carcinoma (HCC) is poorly understood. We explored the expression, biological role, and associated mechanisms of C5AR1 in HBV-related hepatoma cells.
Materials and Methods
The expression of C5ΑR1 mediated by HBV and HBV core protein (HBc) was detected in hepatoma cells. The function of nuclear factor кB (NF-κB) pathway in HBc-induced C5AR1 expression was assessed. The roles of C5ΑR1 in the activation of intracellular signal pathways, the upregulation of inflammatory cytokines, and the growth and migration of hepatoma cells mediated by HBc, were investigated. The effect of C5α in the development of HCC mediated by C5AR1 was also measured.
Results
C5ΑR1 expression was increased in HBV-positive hepatoma cells. Dependent on HBc, HBV enhanced the expression of C5ΑR1 at the mRNA and protein levels. Besides, HBc could promote C5ΑR1 expression via the NF-κB pathway. Based on the C5ΑR1, HBc facilitated the activation of JNK and ERK pathways and the expression and secretion of interleukin-6 in hepatoma cells. Furthermore, C5ΑR1 was responsible for enhancing the growth and migration of hepatoma cells mediated by HBc. Except these, C5α could promote the malignant development of HBc-positive HCC via C5AR1.
Conclusion
We provide new insight into the mechanisms of hepatocarcinogenesis mediated by HBc. C5ΑR1 has a significant role in the functional abnormality of hepatoma cells mediated by HBc, and might be utilized as a potential therapeutic target for HBV-related HCC.

Citations

Citations to this article as recorded by  
  • Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone promote antiviral immune response by activating NF-ĸB
    Peili Hou, Hongchao Zhu, Fengyun Chu, Yan Gao, Xiaonan Sun, Fuzhen Zhang, Xiaomeng Wang, Yueyue Feng, Xingyu Li, Yu Liu, Jun Wang, Xiaoyun Wang, Daniel Chang He, Hongmei Wang, Hongbin He
    Nature Communications.2025;[Epub]     CrossRef
  • HBV core protein enhances WDR46 stabilization to upregulate NUSAP1 and promote HCC progression
    Fanyun Kong, Ensi Bao, Yujie Zhong, Yuxin Wang, Ruyu Liu, Huanyang Zhang, Lu Yang, Rong Jiang, Xuanke Liu, Chen Li, Xiangye Liu, Xiucheng Pan, Kuiyang Zheng, Hongjuan You, Renxian Tang
    Hepatology Communications.2025;[Epub]     CrossRef
  • Transcriptional regulation of tumor suppressor gene RASSF1A by HBx
    Yanhong Kang, Wei Li, Junfeng Wei, Lin Yang, Yi Kang
    Molecular and Cellular Probes.2025; 82: 102034.     CrossRef
  • Hepatitis B virus core protein promotes liver cancer progression by stabilizing CANX and suppressing IRF7 transcription
    Hong-juan You, Huan-yang Zhang, Yu-jie Zhong, Ru-yu Liu, Lu Yang, Rong Jiang, Yu-xin Wang, En-si Bao, Xiang-ye Liu, Chen Li, Xiu-cheng Pan, Xu-feng Huang, Kui-yang Zheng, Ren-xian Tang, Fan-yun Kong
    Acta Pharmacologica Sinica.2025; 46(11): 3036.     CrossRef
  • Effects of interleukin‑6 genetic variation on hepatitis B virus infection and susceptibility to hepatocellular carcinoma: A systematic review and meta‑analysis
    Bibin Antony, Karthikeyan Murugesan, Anjuna Radhakrishnan, Yupa Min, Gowtham Subbaraj
    World Academy of Sciences Journal.2025; 7(4): 1.     CrossRef
  • Understanding the role of C5a/C5aR1-mediated complement activation pathway in tumor progression and therapy resistance
    Lemei Zheng, Jianxia Wei, Mengna Li, Changning Xue, Qingqing Wei, Zubing Wu, Xiaolong Li, Ting Zeng, Huizhen Xin, Wei Xiong, Hongyu Deng, Ming Zhou
    Science China Life Sciences.2025;[Epub]     CrossRef
  • Bioinformatics analysis reveals C5AR1’s impact on thyroid cancer development via immune infiltration
    Yueyao Sun, Lei Xu, Xiaowen Ma, Haobo Wang, Zihao Li, Ji Feng, Tongtong Ji, Qi Wang, Bo Liu, Fangjian Shang
    Scientific Reports.2025;[Epub]     CrossRef
  • Hepatitis B virus core protein stabilizes RANGAP1 to upregulate KDM2A and facilitate hepatocarcinogenesis
    Hong-Juan You, Li-Hong Ma, Xing Wang, Yu-Xin Wang, Huan-Yang Zhang, En-Si Bao, Yu-Jie Zhong, Xiang-Ye Liu, De-Long Kong, Kui-Yang Zheng, Fan-Yun Kong, Ren-Xian Tang
    Cellular Oncology.2024; 47(2): 639.     CrossRef
  • Colchicine-mediated selective autophagic degradation of HBV core proteins inhibits HBV replication and HBV-related hepatocellular carcinoma progression
    Hui Zhang, Xiameng Su, Leirong Gu, Ming Tan, Yuting Liu, Kexin Xu, Jihua Ren, Juan Chen, Zhihong Li, Shengtao Cheng
    Cell Death Discovery.2024;[Epub]     CrossRef
  • Hepatitis B virus X protein increases LASP1 SUMOylation to stabilize HER2 and facilitate hepatocarcinogenesis
    Hongjuan You, Dongchen Yuan, Qi Li, Ning Zhang, Delong Kong, Tong Yu, Xiangye Liu, Xiaomei Liu, Rui Zhou, Fanyun Kong, Kuiyang Zheng, Renxian Tang
    International Journal of Biological Macromolecules.2023; 226: 996.     CrossRef
  • PLK3 promotes the proneural–mesenchymal transition in glioblastoma via transcriptional regulation of C5AR1
    Shuo Yu, Lin Lv, Yang Li, Qian Ning, Tingting Liu, Tinghua Hu
    Molecular Biology Reports.2023; 50(10): 8249.     CrossRef
  • The role of UXT in tumors and prospects for its application in hepatocellular carcinoma
    Zhengwang Wang, Shaojian Mo, Pengzhe Han, Lu Liu, Ziang Liu, Xifeng Fu, Yanzhang Tian
    Future Oncology.2022; 18(29): 3335.     CrossRef
  • C5aR1 promotes the progression of colorectal cancer by EMT and activating Wnt/β-catenin pathway
    Duo Xu, Meirong Li, Longyan Ran, Xiaochen Li, Xingwang Sun, Tao Yin
    Clinical and Translational Oncology.2022; 25(2): 440.     CrossRef
  • The Complement System: A Potential Therapeutic Target in Liver Cancer
    Meng Yuan, Li Liu, Chenlin Wang, Yan Zhang, Jiandong Zhang
    Life.2022; 12(10): 1532.     CrossRef
  • A Pleiotropic Role of the Hepatitis B Virus Core Protein in Hepatocarcinogenesis
    Caroline Lefeuvre, Hélène Le Guillou-Guillemette, Alexandra Ducancelle
    International Journal of Molecular Sciences.2021; 22(24): 13651.     CrossRef
  • 6,371 View
  • 143 Download
  • 15 Crossref
Close layer
Case Report
A Case of Simultaneously Diagnosed Lung Adenocarcinoma and Endobronchial Inflammatory Myofibroblastic Tumor with Two Distinct Types of ALK Translocation
Shikang Zhao, Wei Liu, Shuo Li, Tao Shi, Qiusong Chen, Qi Li, Leina Sun, Dian Ren, Zuoqing Song, Chun Huang, Song Xu
Cancer Res Treat. 2021;53(2):601-606.   Published online October 21, 2020
DOI: https://doi.org/10.4143/crt.2020.952
AbstractAbstract PDFPubReaderePub
A 61-year-old male patient was simultaneously diagnosed with lung adenocarcinoma and inflammatory myofibroblastic tumor (IMT). The lung adenocarcinoma and IMT harbored two distinct types of ALK translocation, LOC101927285-ALK, and TPM3-ALK, respectively. The ALK Ventana showed strong positivity on both lesions. The patient was therefore given an endobronchial cryotherapy and ALK inhibitor crizotinib. The tumors showed durable response however the left lung adenocarcinoma relapsed at 17th month post-crizotinib treatment. Tissue re-biopsy on the resistant tumor revealed an ALK exon 23 C1156Y missense mutation in addition to LOC101927285-ALK mutation. Further RNA-based sequence uncovered that the noncoding region rearrangement is the fusion mutation of EML4-ALK. The patient was therefore received alectinib, and the tumor exhibited partly response. Overall, it is very rare that two types of pulmonary tumors exist in one patient driven by two distinct ALK fusions, which emphasizes the necessity of gene sequencing in clinical decision-making and individualized therapy.

Citations

Citations to this article as recorded by  
  • TTC7A-ALK, a novel ALK fusion variant identified in a patient with metastatic lung adenocarcinoma, exhibits excellent response to crizotinib
    Meijin Huang, Xiangqing Zhu, Wenmang Xu, Jun Zhu, Xin Xun, Bin Su, Hong Chen
    Translational Oncology.2025; 54: 102345.     CrossRef
  • Clinicopathological analysis of 18 cases of inflammatory myofibroblastic tumor in oral and maxillofacial region
    Wei Li, Meng-chen Li, Zi-xuan Fan, Zi-chen Cao, Jie Yang, Xu-dong Yang, Xiao-feng Huang
    BMC Oral Health.2025;[Epub]     CrossRef
  • Retroperitoneal invasive fibromatosis after laparoscopic radical resection of colon cancer: a case report and literature review
    Tiantian Shan, Yiqi Zhang, Yang Yao, Min Li, Xiaoying Li
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • Successful treatment of a non‐small‐cell lung cancer patient harboring HIP1‐ALK (H28:A20) and CTNNB1 p.S45del with alectinib
    Vito Longo, Francesco Pesola, Rosanna Lacalamita, Annamaria Catino, Michele Montrone, Ilaria Marech, Pamela Pizzutilo, Elisabetta Sara Montagna, Stefania Tommasi, Domenico Galetta
    Thoracic Cancer.2024; 15(31): 2283.     CrossRef
  • Coexistence of a novel SV2B-ALK, EML4-ALK double-fusion in a lung poorly differentiated adenocarcinoma patient and response to alectinib: a case report and literature review
    Huang Chen, Menglan Zhang, Liyan Bai, Yun Niu, Xiaowei Wang, Ruiying Jiang, Ye Wang, Qianqian Feng, Bei Wang, Tingli Dai, Mingming Yuan, Rongrong Chen, Yujuan Qi, Dingrong Zhong
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Novel treatment of endobronchial inflammatory myofibroblastic tumor in a child
    Jessica Reyes‐Angel, Louis B. Rapkin, Jeffrey P. Simons, Hiren Muzumdar
    Pediatric Pulmonology.2022; 57(1): 330.     CrossRef
  • Therapeutic Advances of Rare ALK Fusions in Non-Small Cell Lung Cancer
    Yan Xiang, Shiyu Zhang, Xiaoxu Fang, Yingying Jiang, Tingwen Fang, Jinwen Liu, Kaihua Lu
    Current Oncology.2022; 29(10): 7816.     CrossRef
  • Crizotinib in Sarcomatous Malignancies Harboring ALK Fusion With a Definitive Partner(s): Response and Efficacy
    Jinchun Wu, Yongbin Hu, Omar Abdihamid, Gengwen Huang, Sheng Xiao, Bin Li
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • 7,348 View
  • 177 Download
  • 8 Web of Science
  • 8 Crossref
Close layer
Original Article
Central nervous system
Comparison between Craniospinal Irradiation and Limited-Field Radiation in Patients with Non-metastatic Bifocal Germinoma
Bo Li, Wenyi Lv, Chunde Li, Jiongxian Yang, Jiajia Chen, Jin Feng, Li Chen, Zhenyu Ma, Youqi Li, Jiayi Wang, Yanwei Liu, Yanong Li, Shuai Liu, Shiqi Luo, Xiaoguang Qiu
Cancer Res Treat. 2020;52(4):1050-1058.   Published online July 9, 2020
DOI: https://doi.org/10.4143/crt.2020.437
Correction in: Cancer Res Treat 2021;53(2):607
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Whether craniospinal irradiation (CSI) could be replaced by limited-field radiation in non-metastatic bifocal germinoma remains controversial. We addressed the issue based on the data from our series and the literature.
Methods
Data from 49 patients diagnosed with non-metastatic bifocal germinoma at our hospital during the last 10 years were collected. The Pediatric Quality of Life Inventory 4.0 was used to evaluate health-related quality of life (HRQOL). Additionally, 81 patients identified from the literature were also analyzed independently.
Results
In our cohort, 34 patients had tumors in the sellar/suprasellar (S/SS) plus pineal gland (PG) regions and 15 in the S/SS plus basal ganglia/thalamus (BG/T) regions. The median follow-up period was 52 months (range, 10 to 134 months). Our survival analysis showed that patients treated with CSI (n=12) or whole-brain radiotherapy (WBRT; n=34) had comparable disease-free survival (DFS; p=0.540), but better DFS than those treated with focal radiotherapy (FR; n=3, p=0.016). All 81 patients from the literature had tumors in the S/SS+PG regions. Relapses were documented in 4/45 patients treated with FR, 2/17 treated with whole-ventricle irradiation, 0/4 treated with WBRT, and 1/15 treated with CSI. Survival analysis did not reveal DFS differences between the types of radiation field (p=0.785). HRQOL analysis (n=44) in our cohort found that, compared with S/SS+PG germinoma, patients with BG/T involvement had significantly lower scores in social and school domains. However, HRQOL difference between patients treated with CSI and those not treated with CSI was not significant.
Conclusion
In patients with non-metastatic bifocal germinoma, it is rational that CSI could be replaced by limited-field radiation. HRQOL in patients with BG/T involvement was poorer.

Citations

Citations to this article as recorded by  
  • Long-term intelligence after high-dose radiotherapy to the primary site versus chemotherapy and whole-ventricle radiotherapy in patients with germinoma
    Masayuki Kanamori, Yumi Sugawara, Yoshiteru Shimoda, Osamu Iizuka, Yoshinari Osada, Shota Yamashita, Ichiyo Shibahara, Rei Umezawa, Naoko Mori, Ryuta Saito, Yukihiko Sonoda, Toshihiro Kumabe, Keiichi Jingu, Shunji Mugikura, Kyoko Suzuki, Hidenori Endo
    International Journal of Clinical Oncology.2026;[Epub]     CrossRef
  • A systematic review and meta-analysis of x-ray therapy versus proton beam therapy for pediatric central nervous system germ cell tumors: TRP-Germinoma 2025
    Sho Hosaka, Masashi Mizumoto, Hiroko Fukushima, Takashi Iizumi, Takashi Saito, Masako Inaba, Ryoko Suzuki, Yinuo Li, Kei Nakai, Shosei Shimizu, Yoshiko Oshiro, Kazushi Maruo, Hidetoshi Takada, Hideyuki Sakurai
    International Journal of Clinical Oncology.2025; 30(10): 1906.     CrossRef
  • Retrospective investigation of hereditary syndromes in patients with medulloblastoma in a single institution
    Ying Wang, Jingchuan Wu, Wei Li, Jiankang Li, Raynald Liu, Bao Yang, Chunde Li, Tao Jiang
    Child's Nervous System.2021; 37(2): 411.     CrossRef
  • Pineal Gland Tumors: A Review
    Gaia Favero, Francesca Bonomini, Rita Rezzani
    Cancers.2021; 13(7): 1547.     CrossRef
  • Molecular Pathology and Targeted Therapies for Personalized Management of Central Nervous System Germinoma
    Cristina Ilcus, Horatiu Silaghi, Carmen Emanuela Georgescu, Carmen Georgiu, Anca Ileana Ciurea, Simona Delia Nicoara, Cristina Alina Silaghi
    Journal of Personalized Medicine.2021; 11(7): 661.     CrossRef
  • Basal Ganglia Germ Cell Tumors With or Without Sellar Involvement: A Long-Term Follow-Up in a Single Medical Center and a Systematic Literature Review
    Yi Zhang, Li Wang, Wenbin Ma, Hui Pan, Renzhi Wang, Huijuan Zhu, Yong Yao
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • 8,142 View
  • 127 Download
  • 14 Web of Science
  • 6 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP